Feasibility Study of IL-11 and Granulocyte Colony-Stimulating Factor After Myelosuppressive Chemotherapy to Mobilize Peripheral Blood Stem Cells From Heavily Pretreated Patients

Stanton Goldman(Gloucestershire Hospitals NHS Foundation Trust), Mitchell S. Cairo(New York Medical College), Rebecca Slack, Rosemarie Hughes, Carl Lenarsky(University of Iowa), Ellen M. Areman, Joel Weinthal, Francisco Bracho(Georgetown University), Violet Shen(Ruhr University Bochum), Virginia Davenport(Columbia University)
˜The œAmerican journal of pediatric hematology/oncology
June 1, 2001
10.1097/00043426-200106000-00013
Cited by 16

Related Papers

Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
|Journal of Clinical Oncology|2008|794
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
|Blood|2006|431
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
|Blood|2006|362
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome
|Blood|1996|318
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2006|309